These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17896737)

  • 41. Newborn screening policy and practice issues for nurses.
    Tluczek A; De Luca JM
    J Obstet Gynecol Neonatal Nurs; 2013; 42(6):718-29. PubMed ID: 24641079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Current State of Newborn Screening in the United States.
    Fabie NAV; Pappas KB; Feldman GL
    Pediatr Clin North Am; 2019 Apr; 66(2):369-386. PubMed ID: 30819343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screening.
    Cao M; Notini L; Ayres S; Vears DF
    J Genet Couns; 2023 Apr; 32(2):376-386. PubMed ID: 36245433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National academy of clinical biochemistry laboratory medicine practice guidelines: follow-up testing for metabolic disease identified by expanded newborn screening using tandem mass spectrometry; executive summary.
    Dietzen DJ; Rinaldo P; Whitley RJ; Rhead WJ; Hannon WH; Garg UC; Lo SF; Bennett MJ
    Clin Chem; 2009 Sep; 55(9):1615-26. PubMed ID: 19574465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newborn screening in North America.
    Therrell BL; Adams J
    J Inherit Metab Dis; 2007 Aug; 30(4):447-65. PubMed ID: 17643194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical and social issues in newborn screening.
    Wilcken B
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():14-6. PubMed ID: 11400751
    [No Abstract]   [Full Text] [Related]  

  • 47. Early Check: translational science at the intersection of public health and newborn screening.
    Bailey DB; Gehtland LM; Lewis MA; Peay H; Raspa M; Shone SM; Taylor JL; Wheeler AC; Cotten M; King NMP; Powell CM; Biesecker B; Bishop CE; Boyea BL; Duparc M; Harper BA; Kemper AR; Lee SN; Moultrie R; Okoniewski KC; Paquin RS; Pettit D; Porter KA; Zimmerman SJ
    BMC Pediatr; 2019 Jul; 19(1):238. PubMed ID: 31315600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical role of the March of Dimes in the expansion of newborn screening.
    Howse JL; Weiss M; Green NS
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):280-7. PubMed ID: 17183577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expanding newborn screening: process, policy, and priorities.
    Moyer VA; Calonge N; Teutsch SM; Botkin JR;
    Hastings Cent Rep; 2008; 38(3):32-9. PubMed ID: 18581935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.
    Hassan FA; El-Mougy F; Sharaf SA; Mandour I; Morgan MF; Selim LA; Hassan SA; Salem F; Oraby A; Girgis MY; Mahmoud IG; El-Badawy A; El-Nekhely I; Moharam N; Mehaney DA; Elmonem MA
    J Med Screen; 2016 Sep; 23(3):124-9. PubMed ID: 26790708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A primer on expanded newborn screening by tandem mass spectrometry.
    McCandless SE
    Prim Care; 2004 Sep; 31(3):583-604, ix-x. PubMed ID: 15331249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newborn screening for SCID: lessons learned.
    Buelow BJ; Verbsky JW; Routes JM
    Expert Rev Hematol; 2016 Jun; 9(6):579-84. PubMed ID: 27139719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
    Ozben T
    Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Newborn screening: a national public health programme in Brazil.
    de Carvalho TM; dos Santos HP; dos Santos IC; Vargas PR; Pedrosa J
    J Inherit Metab Dis; 2007 Aug; 30(4):615. PubMed ID: 17694357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates.
    Lee H; Lim J; Shin JE; Eun HS; Park MS; Park KI; Namgung R; Lee JS
    Yonsei Med J; 2019 Nov; 60(11):1061-1066. PubMed ID: 31637888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parental permission for pilot newborn screening research: guidelines from the NBSTRN.
    Botkin JR; Lewis MH; Watson MS; Swoboda KJ; Anderson R; Berry SA; Bonhomme N; Brosco JP; Comeau AM; Goldenberg A; Goldman E; Therrell B; Levy-Fisch J; Tarini B; Wilfond B;
    Pediatrics; 2014 Feb; 133(2):e410-7. PubMed ID: 24394680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New tools and approaches to newborn screening: ready to open Pandora's box?
    Ficicioglu C
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001842. PubMed ID: 28487886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.
    Joseph G; Chen F; Harris-Wai J; Puck JM; Young C; Koenig BA
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S36-46. PubMed ID: 26729702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tandem mass spectrometry newborn screening for inborn errors of intermediary metabolism: abnormal profile interpretation.
    Fernández-Lainez C; Aguilar-Lemus JJ; Vela-Amieva M; Ibarra-González I
    Curr Med Chem; 2012; 19(26):4511-22. PubMed ID: 22934775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.